A 42-year-old woman from Mumbai, who is fully vaccinated with 2 doses of inactivated SARS-CoV-2 vaccine (completed 8 months ago), presents with fever (38.5°C), cough, and mild dyspnea for 3 days. She has no comorbidities. On examination, SpO₂ is 94% on room air, and chest X-ray shows minimal infiltrates. RT-PCR confirms SARS-CoV-2 (Omicron variant). Her serum antibody levels are: IgG anti-spike 450 AU/mL (reference >50 = seropositive), IgM anti-spike negative. Which of the following best explains her clinical presentation and serological pattern?

Explanation

## Breakthrough Infection in Vaccinated Individuals ### Serological Pattern Interpretation **Key Point:** The presence of IgG anti-spike (seropositive) with negative IgM indicates prior immune priming (vaccination) rather than primary infection. IgM would be elevated in a truly naive individual experiencing first infection. **High-Yield:** In breakthrough infections: - **IgG persists** from vaccination but may wane over time (8 months post-vaccination is within the waning period). - **IgM is typically absent or minimal** because the immune system recognizes the antigen as "previously encountered" and mounts a secondary (anamnestic) response, which is predominantly IgG. - **IgG levels of 450 AU/mL** are still seropositive but lower than peak post-vaccination levels, reflecting natural decay. ### Why Breakthrough Infections Occur | Factor | Explanation | |--------|-------------| | **Antibody waning** | Neutralizing antibody titers decline 6–12 months post-vaccination, especially against new variants (Omicron) with immune escape mutations | | **Variant escape** | Omicron's spike mutations reduce neutralization by vaccine-induced antibodies; however, vaccine-primed B and T cells can still recognize conserved epitopes | | **T-cell memory preserved** | Vaccination generates long-lived memory T cells (CD4+ and CD8+) that persist for years; these provide protection against severe disease even if antibody levels drop | | **Mild disease phenotype** | T-cell memory limits viral replication and prevents progression to severe pneumonia, ARDS, or death | ### Clinical Correlation in This Patient **Clinical Pearl:** This patient exemplifies a **breakthrough infection with mild disease**: - Fever and mild cough (viral replication still occurs, but controlled). - SpO₂ 94% and minimal infiltrates (T-cell-mediated control prevents alveolar damage). - No severe hypoxemia, no cytokine storm markers expected. **Mnemonic: Breakthrough = Waning Antibodies + Intact T-cells = Mild Disease:** - **W**aning neutralizing antibodies (especially against variants). - **A**ntigen recognition by memory B and T cells (secondary response). - **N**o IgM (anamnestic response, not primary). - **I**ntact T-cell-mediated immunity (controls viral replication and inflammation). - **N**o severe disease (T cells prevent cytokine storm). - **G**ood prognosis (vaccination still protective against mortality). ### Why Omicron Causes Breakthrough Infections Omicron has ~30 mutations in the spike protein, including 15 in the receptor-binding domain (RBD). These mutations: 1. Reduce neutralization by vaccine-induced antibodies (immune escape). 2. Increase transmissibility (higher viral load, faster spread). 3. Do NOT completely escape T-cell recognition (conserved epitopes remain). Result: Vaccinated individuals can still be infected but remain protected against severe disease. [cite:Harrison 21e Ch 197; Lancet 2022 399(10321):142–150]